Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Abstract

URL: https://www.clinicaltrials.gov; Unique identifier: NCT03914326.